WebApr 13, 2024 · Pear Therapeutics, Inc. (NASDAQ:PEAR – Get Rating) major shareholder 5Am Partners Iv, Llc sold 16,544,113 shares of the stock in a transaction on Monday, April 10th.The stock was sold at an average price of $0.12, for a total value of $1,985,293.56. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is … WebJul 7, 2024 · July 07, 2024 08:05 AM Eastern Daylight Time. BOSTON & SAN FRANCISCO-- ( BUSINESS WIRE )-- Pear Therapeutics, Inc. (“Pear” or the “Company”) today announced that it closed a credit ...
Softbank-Backed Pear Therapeutics Plans To Go Public In …
WebBased on 3 analyst s offering 12 month price targets for Pear Therapeutics Inc. Min Forecast $1.00 +309.84% Avg Forecast $4.67 +1,812.7% Max Forecast $8.00 +3,178.69% Should I buy or sell PEAR stock? All Analysts Top Analysts Based on 3 analyst s offering ratings for Pear Therapeutics Inc. Buy Strong Buy 1 analysts 33.33% Buy 0 analysts 0% Hold WebApr 10, 2024 · SEC Filings - Pear Therapeutics, Inc. SEC Filings SEC Filings Quarterly Results Annual Reports - Any - 1 2 3 4 5 6 7 8 9 … Next › Last » Data provided by Boston 200 State … strawberry tour 2022
Netalie Nadivi sur LinkedIn : The unfortunate demise of Pear ...
WebApr 14, 2024 · Pear Therapeutics, Inc. (NASDAQ:PEAR – Get Rating) major shareholder 5Am Partners Iv, Llc sold 16,544,113 shares of the business’s stock in a transaction that occurred on Monday, April 10th ... WebJul 20, 2024 · Pear Therapeutics is a biotechnology and software company. It offers prescription digital therapeutics that that seek to manage or treat psychiatric and … strawberry tours